PBYIPUMA BIOTECHNOLOGY, INC.vs its industry peers
A metric-by-metric comparison of PUMA BIOTECHNOLOGY, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PBYIEsta | $478M#7 | 18.2x#3 | 3.5x#10 | 2.1x#3 | -0.9%#5 | 2.8%#5 | 16.3%#1 | 22.5%#1 | — | — | 99.8%#2 | — |
| ASMB | $531M#1 | 21.0x#4 | 1.7x#3 | 7.3x#6 | 153.5%#2 | 84.8%#1 | -16.8%#3 | -2.0%#3 | -4.4%#1 | — | 22.9%#6 | — |
| EOLS | $522M#2 | — | — | 1.8x#2 | 11.6%#4 | -2.4%#6 | -11.0%#2 | — | -40.5%#2 | 4#1 | 19.3%#7 | — |
| MPLT | $513M#3 | 0.3x#1 | 1.5x#1 | — | — | -107.7%#11 | — | -46.3%#6 | — | — | — | — |
| CAPR | $498M#4 | — | 2.0x#4 | — | -100.0%#10 | -159.6%#13 | — | -42.7%#5 | — | — | 41.9%#5 | — |
| IRD | $483M#5 | — | — | 34.0x#7 | 29.1%#3 | 13.8%#3 | -271.9%#7 | — | — | — | 326.8%#1 | — |
| INDP | $482M#6 | — | 42.4x#12 | — | — | -38.8%#8 | — | -183.3%#11 | — | — | 57.4%#4 | — |
| RLMD | $475M#8 | — | 2.3x#6 | 92548.4x#9 | -35.4%#7 | — | -1152275.3%#9 | 0.0%#2 | — | — | — | — |
| ARCT | $450M#9 | — | 2.6x#7 | 5.5x#5 | -46.1%#8 | 18.7%#2 | -93.0%#5 | -38.3%#4 | -136.2%#4 | — | — | — |
| PRTA | $429M#10 | — | 1.5x#2 | 44.3x#8 | -92.8%#9 | -99.6%#9 | -2216.4%#8 | -85.1%#9 | — | — | — | — |
| SPRY | $421M#11 | — | 33.7x#11 | 5.0x#4 | -5.5%#6 | -2241.8%#14 | -212.9%#6 | -1369.1%#13 | -177.6%#5 | — | — | — |
| AVIR | $419M#12 | — | 2.1x#5 | 1.2x#1 | 622.5%#1 | 6.0%#4 | -51.5%#4 | -77.4%#8 | — | — | 72.3%#3 | — |
| GTBP | $410M#13 | 1.7x#2 | 114.8x#13 | — | — | -115.4%#12 | — | -794.5%#12 | — | — | -54.8%#8 | 0.1%#1 |
| LRMR | $408M#14 | — | 3.2x#8 | — | — | -105.5%#10 | — | -130.1%#10 | -350.3%#6 | — | — | — |
| RZLT | $402M#15 | — | 3.4x#9 | — | — | -8.7%#7 | — | -63.7%#7 | -72.2%#3 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice